Clinical trials
Phase 2 Triple Negative Breast Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| AstraZeneca | 2 |
| Novartis Pharmaceuticals | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| CytomX Therapeutics | 1 |
| Gilead Sciences | 1 |
| National Cancer Center, Korea | 1 |
| Odonate Therapeutics, Inc. | 1 |
| Queen Mary University of London | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 17 |
| Breast Neoplasms | 9 |
| Stomach Neoplasms | 3 |
| Neoplasm Metastasis | 2 |
| Ovarian Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Cholangiocarcinoma | 1 |
| Colorectal Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.